Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study)

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are considered to have the potential to maintain renal function by correcting glomerular hypertension in patients with diabetic kidney disease (DKD). The aim of this study is to demonstrate the renoprotective effect of SGLT2i by measurin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Sawako, Kuwatsuka, Yachiyo, Ando, Masahiko, Tatematsu, Yoshitaka, Nishibori, Nobuhiro, Maruyama, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401745/
https://www.ncbi.nlm.nih.gov/pubmed/37537531
http://dx.doi.org/10.1186/s12882-023-03277-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401745/
https://www.ncbi.nlm.nih.gov/pubmed/37537531
http://dx.doi.org/10.1186/s12882-023-03277-0

Ejemplares similares